Delivery Order SPE2DB24D8002-SPE2DB25FJNKC
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,208.44 firm-fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,354.77 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product, with a completion date of September 19, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $8,811.79 and a period of performance through February 24, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S. The ceiling value of this contract is $2,910.31, with an ultimate completion date of October 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The...
The federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,266.56 firm fixed-price delivery order is for the supply of ENTRESTO 24 MG-26 MG TABLET 60S, with a completion date of May 22, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This federal contract award, valued at $6,292.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 60S, with a period of performance through May 21, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $4,002.30. The contract has an ultimate completion date of April 29, 2024 and is a firm fixed-price agreement. Dakota Drug, Inc. is the prime contractor and has not been awarded any federal grants or additional prime...
This federal contract award, valued at $14,527.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S. The contract is a firm-fixed-price delivery order with a period of performance through October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,313.18 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of 60 tablets of the pharmaceutical product Entresto, a medication used to treat heart failure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA under the agency's ECAT Generation V...